Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders

Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) from a geno-identical matched sibling (MSD) is one of the most successful therapies in patients with non-malignant hematological disorders. This study included 273 patients with severe aplastic anemia (SAA), 152 patients with B-Thalassem...

Full description

Bibliographic Details
Main Authors: Hossam K. Mahmoud, Alaa M. Elhaddad, Omar A. Fahmy, Mohamed A. Samra, Raafat M. Abdelfattah, Yasser H. El-Nahass, Gamal M. Fathy, Mohamed S. Abdelhady
Format: Article
Language:English
Published: Elsevier 2015-05-01
Series:Journal of Advanced Research
Subjects:
Hematopoietic stem cell transplantation
B-thalassemia major
Fanconi’s anemia
Immunodeficiency diseases
Inherited metabolic disorders
Online Access:http://www.sciencedirect.com/science/article/pii/S2090123214001349

Internet

http://www.sciencedirect.com/science/article/pii/S2090123214001349

Similar Items